scholarly journals Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson’s Disease?

2017 ◽  
Vol 7 (4) ◽  
pp. 577-587 ◽  
Author(s):  
Keerthi Thirtamara-Rajamani ◽  
Peipei Li ◽  
Martha L. Escobar Galvis ◽  
Viviane Labrie ◽  
Patrik Brundin ◽  
...  
2014 ◽  
Vol 29 (8) ◽  
pp. 990-990
Author(s):  
Sheila M. Fleming ◽  
Alberto J. Espay

Author(s):  
Mansi Verma ◽  
Sujata Basu ◽  
Manisha Singh ◽  
Rachana R. ◽  
Simrat Kaur ◽  
...  

Parkinson's disease (PD) has been reported to be the most common neurodegenerative diseases all over the world. Several proteins are associated and responsible for causing PD. One such protein is α-synuclein. This chapter discusses the role of α-synuclein in PD. Various genetic and epigenetic factors, which cause structural and functional changes for α-synuclein, have been described. Several molecular mechanisms, which are involved in regulating mitochondrial and lysosomal related pathways and are linked to α-synuclein, have been discussed in detail. The knowledge gathered is further discussed in terms of using α-synuclein as a diagnostic marker for PD and as a novel therapeutic target for the same.


Author(s):  
Efthalia Angelopoulou ◽  
Yam Nath Paudel ◽  
Thomas Julian ◽  
Mohd Farooq Shaikh ◽  
Christina Piperi

2016 ◽  
Vol 22 (10) ◽  
pp. 1305-1311 ◽  
Author(s):  
Juan Camilo Jurado-Coronel ◽  
Marco Avila-Rodriguez ◽  
Francisco Capani ◽  
Janneth Gonzalez ◽  
Valentina Echeverria Moran ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document